Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark is supported by a resilient portfolio anchored in personal care and consumer tissue, with brands like Huggies, Kleenex, and Cottonelle that benefit from steady everyday demand and durable category positions. Its geographic diversification across North America, Europe, Asia, and Latin America, plus the professional segment, helps offset regional volatility, while expected +1-3% organic sales growth and +1-3% EPS growth in 2026-28 suggest modest but steady fundamental improvement. The planned addition of Kenvue’s consumer health portfolio in the second half of calendar year 2026 could broaden the mix and add earnings accretion, reinforcing a constructive long-term outlook despite investor concerns around near-term organic growth.

Kimberly-Clark is facing a weaker fundamental backdrop as postponed innovation launches and inventory de-loading are creating roughly 2 percentage points of incremental top-line pressure in 3Q26, while China is still expected to weigh on growth by about 250-300 basis points. Higher freight and logistics costs add about $30-40 million, and Canadian retaliatory tariffs contribute another $10 million, compounding margin pressure at a time when the company is already modeling -1.3% organic revenue decline and -13.0% EPS decline in 3Q26. Although the Kenvue deal may be more attractive than initially expected, skepticism around sustainable organic growth remains, reinforced by only modestly improving momentum across its globally diversified but mature household and personal care portfolio.